Karin Lykke-Hartmann Selected Research

Nicotine

9/2013

The dormant and the fully competent oocyte: comparing the transcriptome of human oocytes from primordial follicles and in metaphase II.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karin Lykke-Hartmann Research Topics

Disease

6	familial type 2 Hemiplegic migraine 01/2022 - 02/2012
5	Dystonia 12 05/2017 - 03/2013
4	Dystonia (Limb Dystonia) 05/2017 - 02/2011
3	Migraine Disorders (Migraine) 01/2022 - 02/2012
3	Alternating hemiplegia of childhood 05/2017 - 01/2016
3	Nervous System Diseases (Neurological Disorders) 01/2016 - 12/2013
2	Migraine with Aura (Familial Hemiplegic Migraine) 01/2022 - 11/2017
2	Ischemia 01/2019 - 01/2017
2	Movement Disorders (Movement Disorder) 05/2017 - 03/2013
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2017 - 01/2017
2	Parkinsonian Disorders (Parkinsonism) 02/2012 - 02/2011
1	Heart Diseases (Heart Disease) 01/2022
1	Heart Failure 01/2022
1	Peripheral Nerve Injuries 01/2019
1	Brain Ischemia (Cerebral Ischemia) 01/2019
1	Hyperalgesia 01/2019
1	Infarction (Infarctions) 01/2019
1	Neuralgia (Stump Neuralgia) 01/2019
1	Pain (Aches) 01/2019
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2019
1	Stroke (Strokes) 01/2019
1	Epilepsy (Aura) 11/2018
1	Inflammation (Inflammations) 01/2017
1	Neural Tube Defects (Exencephaly) 01/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017
1	Contusions 01/2017
1	CAPOS syndrome 01/2016
1	Hemiplegia (Spastic Hemiplegia) 01/2016
1	Ataxia (Dyssynergia) 01/2016
1	Seizures (Absence Seizure) 01/2016
1	Primary Ovarian Insufficiency 09/2013
1	Folic Acid Deficiency (Folic Acid Deficiencies) 09/2013
1	Spasm (Spasms) 03/2013
1	Neurologic Manifestations (Neurological Manifestations) 02/2012

Drug/Important Bio-Agent (IBA)

13	Adenosine Triphosphatases (ATPase)IBA 01/2022 - 02/2011
10	Protein Isoforms (Isoforms)IBA 01/2022 - 02/2011
2	Glutamic Acid (Glutamate)FDA Link 11/2017 - 02/2016
2	Sodium-Potassium-Exchanging ATPase (Sodium, Potassium ATPase)IBA 05/2017 - 02/2012
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2017 - 09/2013
2	Ion Pumps (Ion Pump)IBA 01/2017 - 01/2016
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	Malondialdehyde (Propanedial)IBA 01/2022
1	src-Family KinasesIBA 01/2022
1	sortilinIBA 01/2019
1	Tat-NR2B9cIBA 01/2019
1	AntibodiesIBA 01/2019
1	NeurotensinIBA 01/2019
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2019
1	N-Methylaspartate (NMDA)IBA 01/2019
1	Neurotensin Receptors (Neurotensin Receptor)IBA 01/2019
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2019
1	UCCB01-144IBA 01/2019
1	Gonadal Steroid Hormones (Sex Hormones)IBA 11/2018
1	Proteins (Proteins, Gene)FDA Link 11/2017
1	Adenosine Triphosphate (ATP)IBA 01/2017
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2017
1	NF-kappa B (NF-kB)IBA 01/2017
1	Nicotine FDA Link 09/2013
1	PotassiumIBA 02/2011
1	SodiumIBA 02/2011

Therapy/Procedure

1	Induced Hypothermia 05/2017